Drug
Rebamipide clinical trials
Also written Mucosta.
- studies test it
- 38
- open now
- 4
- in phase 3
- 10
- first study started
- 2004
Keep track of what changes. Save the rebamipide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Development codes
Studies by the year they started
38 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2004 | 3 |
| 2005 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 9
- Phase 3
- 10
- Phase 4
- 10
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 15
Otsuka Pharmaceutical Co., Ltd. (9) · Korea Otsuka Pharmaceutical Co., Ltd. (3) · Kubota Vision Inc. (3) · Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Samsung Medical Center (2) · Cairo University (2) · Pirogov Russian National Research Medical University (1) · Korea University Anam Hospital (1)
Often tested with
Tested in the same studies.
Pantoprazole (1) · Diquafosol (1) · Polaprezinc (1) · Celecoxib (1) · Mosapride (1) · Omeprazole (1) · Esomeprazole (1) · Diosmin (1)
Studies
Open first, then newest update. How each study uses rebamipide is read from its arms, and is right about nine times in ten.
Testing it · 38
- Evaluation of Topical Rebamipide Versus Topical Betamethasone for Treatment of Oral Aphthous UlcersRecruitingPhase 2Cairo UniversityNCT06084624Written as Rebamipide mouthwash
- Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid ArthritisRecruitingPhase 2Tanta UniversityNCT07745426Written as Rebamipide 100mg
- Rebamipide Versus Diquafosol for Perioperative Dry Eye in Cataract SurgeryNot yet recruitingPhase 4Samsung Medical CenterNCT07397949Written as Rebamipide 2% ophthalmic solution
- Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis PatientsRecruitingPhase 3Cairo UniversityNCT04649697Written as Rebamipide
- Study of Rebamipide Eye Drops to Treat Dry EyeCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT00201955Written as Rebamipide 1%
- A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a PlaceboCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT00201981Written as Rebamipide 1%
- Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract SurgeryCompletedPhase 4Samsung Medical CenterNCT07397936Written as Rebamipide 2% ophthalmic solution
- Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACsCompletedPhase 4Pirogov Russian National Research Medical UniversityNCT07354230Written as Rebamipide 100mg
- Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye DiseaseCompletedPhase 4Korea University Anam HospitalNCT07297316Written as 3% diquafosol (right eye) and 2% rebamipide (left eye)
- Rebamipide in Patients With Active Rheumatoid ArthritisCompletedPhase 1/2October 6 UniversityNCT05166304Written as Rebamipide
- An Exploratory Study of Rebamipide in Patients With Active Ulcerative ColitisCompletedPhase 2Otsuka Pharmaceutical Co., Ltd.NCT00463151Written as rebamipide
- Safety Study of OPC-12759 Ophthalmic SolutionCompletedPhase 1Otsuka Pharmaceutical Co., Ltd.NCT01471093Written as OPC-12759 Ophthalmic solution
- Post-marketing Clinical Study of Rebamipide in Patients With Gastric UlcerCompletedPhase 4Otsuka Pharmaceutical Co., Ltd.NCT00233389Written as Rebamipide
- Exploratory Study for Dry Mouth in Patients With Sjögren's SyndromeCompletedPhase 2Otsuka Pharmaceutical Co., Ltd.NCT00233363Written as Rebamipide
- Confirmatory Study of OPC-12759 Ophthalmic SolutionCompletedPhase 3Otsuka Pharmaceutical Co., Ltd.NCT01660256Written as OPC-12759
- Rebamipide AND Sjögren SyndromeStatus unknownNot applicableUniversity of AlexandriaNCT01759108Written as Rebamipide
- To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy VolunteersCompletedPhase 1Korea Otsuka Pharmaceutical Co., Ltd.NCT04150172Written as Rebamipide SR 150mg
- To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy VolunteersCompletedPhase 1Korea Otsuka Pharmaceutical Co., Ltd.NCT04150146Written as Rebamipide SR 150mg after high-fat meal
- The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced UlcerCompletedNot applicableYonsei UniversityNCT02243618Written as Rebamipide
- Comparison Between Rebamipide 2% Versus Autologous SerumCompletedPhase 4Hospital Nacional Profesor Alejandro PosadasNCT03608761Written as Rebamipide
See all 38 studies that test rebamipide →
Given in every arm · 2 — rebamipide is usual care beside what is tested
- A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With GastritisCompletedPhase 3Korea Otsuka Pharmaceutical Co., Ltd.NCT04189705Written as Mucosta Tab.
- Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional DyspepsiaStatus unknownPhase 4University of MalayaNCT02134405Written as Rebamipide
As the comparator · 3 — what is tested is compared with rebamipide
- Compare the Effect of Eupatilin and Rebamipide on the Prevention of GastroenteropathyStatus unknownPhase 4Seoul National University Boramae HospitalNCT04885751Written as Rebamipide
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 TabletCompletedPhase 2Chong Kun Dang PharmaceuticalNCT03437785Written as Rebamipide 100mg
- A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034Status unknownPhase 3Dong-A Pharmaceutical Co., Ltd.NCT01813812Written as Rebamipide 300mg
Codes
What other systems call rebamipide · ClinicalTrials.gg INT003328
- MeSH (NLM) C052785rebamipideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) LR583V32ZRREBAMIPIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q7301602rebamipideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29852RebamipideOne source FDA
- DrugBank DB11656One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C052785 | rebamipide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | LR583V32ZR | REBAMIPIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7301602 | rebamipide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29852 | Rebamipide | One source FDA |
| DrugBank | DB11656 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.